GS-441524 oral tablets are designed for feline use, mainly intended for cases associated with feline infectious peritonitis (FIP). The active compound is a nucleoside analog that works by interfering with viral RNA replication, helping to reduce viral activity at the cellular level.
Unlike injectable versions, the oral form offers a more practical and stress-free administration method. It is especially suitable for long-term care situations, including home treatment and multi-cat environments, where ease of dosing and reduced handling stress are important.
| Item | Description |
|---|---|
| Product Name | GS-441524 Tablets |
| CAS Number | 1191237-69-0 |
| Dosage Form | Oral Tablets |
| Strength Options | 20mg / 40mg / 50mg / 60mg |
| Packaging | 10 tablets per bag |
| Shelf Life | 12 months |
| Storage Condition | Room temperature or 2–4°C, protected from light |
| Origin | China |
| Function | Supportive management of feline FIP |
GS-441524 acts as a nucleoside analog, mimicking natural building blocks of RNA. Once incorporated into the viral RNA chain, it disrupts further replication, leading to premature termination of viral genome synthesis.
This mechanism helps:
Compared with injectable formulations, tablets offer several practical advantages:
FIP is a serious disease in cats caused by a mutation of feline coronavirus (FCoV). While many cats may carry the virus without symptoms, certain mutations can trigger severe systemic inflammation.
Due to its complex nature, FIP requires careful monitoring and long-term management strategies.
Each pack contains 10 tablets in sealed packaging to ensure product stability and protection during transport.
We support flexible shipping options and both small and bulk orders, ensuring consistent supply for different business needs.
